Obesity is primarily due to food intake in excess of the body’s
energetic requirements, intake that is not only associated with hunger but also
the incentive value of food. The 5-hydroxytryptamine 2C receptor
(5-HT2CR) is a target for the treatment of human obesity.
Mechanistically, 5-HT2CRs are positioned to influence both
homeostatic feeding circuits within the hypothalamus and reward circuits within
the ventral tegmental area (VTA). Here we investigated the role of
5-HT2CRs in incentive motivation using a mathematical model of
progressive ratio (PR) responding in mice. We found that the 5-HT2CR
agonist lorcaserin significantly reduced both ad libitum chow intake and PR
responding for chocolate pellets and increased c-fos expression in VTA
5-HT2CR expressing γ-aminobutyric acid (GABA) neurons, but
not 5-HT2CR expressing dopamine (DA) neurons. We next adopted a
chemogenetic approach using a 5-HT2CRCRE
line to clarify the function of subset of 5-HT2C receptor expressing
VTA neurons in the modulation of appetite and food motivated behavior.
Activation of VTA 5-HT2C receptor expressing neurons significantly
reduced ad libitum chow intake, operant responding for chocolate pellets and the
incentive value of food. In contrast, chemogenetic inhibition of VTA
5-HT2C receptor expressing neurons had no effect on feeding
behavior. These results indicate that activation of the subpopulation of
5-HT2CR neurons within the VTA is sufficient to significantly
reduce homeostatic feeding and effort-based intake of palatable food, and that
this subset plays an inhibitory role in motivational processes. These findings
are relevant to the treatment of obesity.